Embrace Real-World Evidence To Avoid Costly Prospective Randomized Trials That Can ‘Strangle Innovation,’ RWE Expert Says

By Shawn M. Schmitt Communications Specialist, Enzyme The widespread collection and use of real-world data (RWD) by pharmaceutical and MedTech manufacturers to support new product submissions is teetering on a tipping point in these industries, yet one expert and longtime RWD proponent says many companies are still gun-shy about presenting such data to a regulator’s…